The FDA is reviewing the black box warning on estrogen used in menopause treatments. The potential policy shift could change how millions of women manage menopause symptoms and reshape conversations around hormone therapy safety.
The FDA is reviewing the black box warning on estrogen used in menopause treatments. The potential policy shift could change how millions of women manage menopause symptoms and reshape conversations around hormone therapy safety.